🇺🇸 FDA
Patent

US 8603462

Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction

granted A61KA61K35/22A61K35/28

Quick answer

US patent 8603462 (Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction) held by The United States of America—Department of Veterans Affairs expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America—Department of Veterans Affairs
Grant date
Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K35/22, A61K35/28, A61K35/44, A61K38/195